From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses

Respir Res. 2020 Aug 27;21(1):224. doi: 10.1186/s12931-020-01479-w.

Abstract

Within two decades, there have emerged three highly pathogenic and deadly human coronaviruses, namely SARS-CoV, MERS-CoV and SARS-CoV-2. The economic burden and health threats caused by these coronaviruses are extremely dreadful and getting more serious as the increasing number of global infections and attributed deaths of SARS-CoV-2 and MERS-CoV. Unfortunately, specific medical countermeasures for these hCoVs remain absent. Moreover, the fast spread of misinformation about the ongoing SARS-CoV-2 pandemic uniquely places the virus alongside an annoying infodemic and causes unnecessary worldwide panic. SARS-CoV-2 shares many similarities with SARS-CoV and MERS-CoV, certainly, obvious differences exist as well. Lessons learnt from SARS-CoV and MERS-CoV, timely updated information of SARS-CoV-2 and MERS-CoV, and summarized specific knowledge of these hCoVs are extremely invaluable for effectively and efficiently contain the outbreak of SARS-CoV-2 and MERS-CoV. By gaining a deeper understanding of hCoVs and the illnesses caused by them, we can bridge knowledge gaps, provide cultural weapons for fighting and controling the spread of MERS-CoV and SARS-CoV-2, and prepare effective and robust defense lines against hCoVs that may emerge or reemerge in the future. To this end, the state-of-the-art knowledge and comparing the biological features of these lethal hCoVs and the clinical characteristics of illnesses caused by them are systematically summarized in the review.

Keywords: Biological features; Clinical characteristics; Illness; MERS-CoV; SARS-CoV; SARS-CoV-2.

Publication types

  • Comparative Study
  • Systematic Review

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Communicable Disease Control
  • Coronavirus Infections / epidemiology*
  • Female
  • Global Health
  • Humans
  • Male
  • Middle East Respiratory Syndrome Coronavirus / pathogenicity*
  • Pandemics / statistics & numerical data*
  • Pneumonia, Viral / epidemiology*
  • Prevalence
  • Risk Assessment
  • SARS-CoV-2
  • Severe Acute Respiratory Syndrome / epidemiology*
  • Severe acute respiratory syndrome-related coronavirus / pathogenicity*
  • Survival Analysis
  • World Health Organization